rs28903090

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_005732.4(RAD50):​c.943G>T​(p.Val315Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00221 in 1,612,604 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. V315V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0023 ( 5 hom. )

Consequence

RAD50
NM_005732.4 missense

Scores

2
6
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:5

Conservation

PhyloP100: 7.88

Publications

18 publications found
Variant links:
Genes affected
RAD50 (HGNC:9816): (RAD50 double strand break repair protein) The protein encoded by this gene is highly similar to Saccharomyces cerevisiae Rad50, a protein involved in DNA double-strand break repair. This protein forms a complex with MRE11 and NBS1. The protein complex binds to DNA and displays numerous enzymatic activities that are required for nonhomologous joining of DNA ends. This protein, cooperating with its partners, is important for DNA double-strand break repair, cell cycle checkpoint activation, telomere maintenance, and meiotic recombination. Knockout studies of the mouse homolog suggest this gene is essential for cell growth and viability. Mutations in this gene are the cause of Nijmegen breakage syndrome-like disorder.[provided by RefSeq, Apr 2010]
RAD50 Gene-Disease associations (from GenCC):
  • Nijmegen breakage syndrome-like disorder
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.015402764).
BP6
Variant 5-132587981-G-T is Benign according to our data. Variant chr5-132587981-G-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 128028.
BS2
High Homozygotes in GnomAdExome4 at 5 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005732.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RAD50
NM_005732.4
MANE Select
c.943G>Tp.Val315Leu
missense
Exon 7 of 25NP_005723.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RAD50
ENST00000378823.8
TSL:1 MANE Select
c.943G>Tp.Val315Leu
missense
Exon 7 of 25ENSP00000368100.4Q92878-1
ENSG00000283782
ENST00000638452.2
TSL:5
c.646G>Tp.Val216Leu
missense
Exon 9 of 27ENSP00000492349.2A0A1W2PQ90
RAD50
ENST00000533482.5
TSL:1
n.*569G>T
non_coding_transcript_exon
Exon 7 of 25ENSP00000431225.1E9PM98

Frequencies

GnomAD3 genomes
AF:
0.00133
AC:
203
AN:
152150
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000627
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000916
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00237
Gnomad OTH
AF:
0.000959
GnomAD2 exomes
AF:
0.00120
AC:
299
AN:
250054
AF XY:
0.00115
show subpopulations
Gnomad AFR exome
AF:
0.000557
Gnomad AMR exome
AF:
0.00151
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00205
Gnomad OTH exome
AF:
0.00115
GnomAD4 exome
AF:
0.00230
AC:
3366
AN:
1460336
Hom.:
5
Cov.:
31
AF XY:
0.00218
AC XY:
1583
AN XY:
726570
show subpopulations
African (AFR)
AF:
0.000389
AC:
13
AN:
33446
American (AMR)
AF:
0.00145
AC:
65
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26118
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39576
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86230
European-Finnish (FIN)
AF:
0.0000937
AC:
5
AN:
53358
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.00288
AC:
3196
AN:
1110786
Other (OTH)
AF:
0.00141
AC:
85
AN:
60340
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
171
341
512
682
853
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
138
276
414
552
690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00133
AC:
203
AN:
152268
Hom.:
0
Cov.:
32
AF XY:
0.00118
AC XY:
88
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.000626
AC:
26
AN:
41562
American (AMR)
AF:
0.000915
AC:
14
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00237
AC:
161
AN:
68008
Other (OTH)
AF:
0.000949
AC:
2
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
13
26
40
53
66
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00154
Hom.:
0
Bravo
AF:
0.00137
TwinsUK
AF:
0.00378
AC:
14
ALSPAC
AF:
0.00389
AC:
15
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00267
AC:
23
ExAC
AF:
0.00125
AC:
152
EpiCase
AF:
0.00234
EpiControl
AF:
0.00119

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
1
not provided (3)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
1
1
Nijmegen breakage syndrome-like disorder (2)
-
1
1
not specified (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.65
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.074
T
Eigen
Uncertain
0.51
Eigen_PC
Uncertain
0.57
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.96
D
M_CAP
Benign
0.019
T
MetaRNN
Benign
0.015
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.3
M
PhyloP100
7.9
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
-0.74
N
REVEL
Benign
0.20
Sift
Benign
0.41
T
Sift4G
Benign
0.25
T
Polyphen
0.78
P
Vest4
0.51
MutPred
0.21
Loss of MoRF binding (P = 0.0988)
MVP
0.47
ClinPred
0.028
T
GERP RS
5.4
Varity_R
0.24
gMVP
0.33
Mutation Taster
=64/36
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28903090; hg19: chr5-131923673; COSMIC: COSV99037104; COSMIC: COSV99037104; API